TELOMIR PHARMACEUTICALS INC (TELO) Stock Cash Flow
USA - NASDAQ:TELO - US87975F1049 - Common Stock
1.9691 USD
+0.32 (+19.34%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.08M | -16.53M | -13.07M | -854.20K | -138.10K | |||
| Change In Working Capital | -126.30K | 126.50K | 113.80K | 385.50K | 18.70K | |||
| Other non cash items | 13.04M | 11.34M | 9.10M | N/A | N/A | |||
| OPERATING CASH FLOW | -3.17M | -5.07M | -3.86M | -468.70K | -119.40K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 3.17M | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 6.87M | 1.00M | N/A | N/A | |||
| Other Financing Activity | N/A | -535.00K | -310.40K | 470.10K | 119.40K | |||
| FINANCING CASH FLOW | N/A | 6.34M | 3.86M | 470.10K | 119.40K | |||
| CHANGE IN CASH | -1.13M | 1.26M | -200.00 | 1.40K | 0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.17M | -5.07M | -3.86M | -468.70K | -119.40K | |||
| FREE CASH FLOW | -3.17M | -5.07M | -3.86M | -468.70K | -119.40K | |||
All data in USD